相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- CAS号:
2624-44-4
- 规格:
1g/1mLx10mM(inDMSO)/50mg/100mg/500mg
| 规格: | 1g | 产品价格: | ¥495.0 |
|---|---|---|---|
| 规格: | 1mLx10mM(inDMSO) | 产品价格: | ¥95.0 |
| 规格: | 50mg | 产品价格: | ¥159.0 |
| 规格: | 100mg | 产品价格: | ¥213.0 |
| 规格: | 500mg | 产品价格: | ¥342.0 |
Product Introduction
Bioactivity
| 名称 | Ethamsylate |
| 描述 | Ethamsylate (Dicynene) usually is used as a hemostatic drug, which increases capillary endothelial resistance and platelet adhesion, and inhibits biosynthesis and action of prostaglandins. |
| 体外活性 | Ethamsylate通过抑制血栓烷A2和前列环素的生物合成,降低脑室内出血的效应.Ethamsylate大鼠口服剂量>25 mg/kg ,能够抑制角叉菜胶诱导的足肿胀.兔全身或口服Ethamsylate时,能够缩短其平均出血时间.Ethamsylate静脉给药的剂量>5 mg/kg,可缩短一半的出血时间.注射后5分钟开始发挥效应,在注射后30 分钟和4小时之间达到效应最大值,6小时后效应消失.口服10 mg/kg Ethamsylate时,也能够出现相似的最大效应. |
| 体内活性 | 高浓度Ethamsylate能够除去超氧自由基。在Ethamsylate的作用下,花生四烯酸,血栓素A2,胶原蛋白,和钙离子载体A23187会促进诱导人血小板发生聚集并引起ATP的释放。Ethamsylate在其IC50 为0.5 mM时,能够抑制孕妇子宫肌层微粒体中的前列腺素的产生。 Ethamsylate在浓度为0.1–10 μM时,能够高效地抑制hydroxyl radicals (OH.)。 |
| 存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | DMSO : 50 mg/mL (189.89 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2.5 mg/mL (9.49 mM), Sonication is recommended. |
| 关键字 | ProstaglandinReceptor | Prostaglandin Receptor | Inhibitor | inhibit | Ethamsylate |
| 相关产品 | Rutin | Evodiamine | Lornoxicam | p-Hydroxycinnamic acid | Nepafenac | Rebamipide | Tranilast | Ufenamate | Angoroside C | Ozagrel | Amtolmetin guacil | Pranoprofen |
| 相关库 | Inhibitor Library | Bioactive Compound Library | Anti-Cancer Approved Drug Library | Bioactive Compounds Library Max | Anti-Aging Compound Library | GPCR Compound Library | Membrane Protein-targeted Compound Library | Immunology/Inflammation Compound Library | Drug Repurposing Compound Library | Pain-Related Compound Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Drug Library |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
官网有文献
相关实验
Overview of Formation of G‐Quadruplex Structures
promoter. Biochemistry 44: 16341‐16350. Arnal‐Hérault, C., Banu, A., Barboiu, M., Michau, M., and van der Lee, A. 2007. Amplification and transcription of the dynamic
技术资料暂无技术资料 索取技术资料
文献支持
酚磺乙胺【2624-44-4】
¥95 - 495










